Presence of Anti-drug Antibodies Does Not Reduce the Efficacy of an Oral Anti-TNF Antibody in a Murine IBD Model

被引：0
|
作者：
Bhol, Kailash [1 ]
Erlich, Emma [1 ]
Lemos, Brenda [1 ]
Tracey, Daniel [1 ]
Hartman, Deborah [1 ]
Fox, Barbara [1 ]
机构：
[1] Avaxia Biol Inc, Lexington, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-01810
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1810
引用
收藏
页码：S545 / S546
页数：2
相关论文
共 50 条
  • [31] Measurement of Anti-TNF Agents and Anti-Drug Antibodies Serum Levels in Patients with Inflammatory Bowel Disease
    Guerra, Ivan
    Chaparro, Maria
    Bermejo, Fernando
    Gisbert, Javier P.
    [J]. CURRENT DRUG METABOLISM, 2014, 15 (09) : 875 - 881
  • [32] IMPACT OF BODY MASS INDEX (BMI) UPON ANTI-TNF TROUGH AND ANTI-DRUG ANTIBODY LEVELS
    Bond, A.
    Sager, K.
    Phillips, S.
    Asher, R.
    Jackson, R.
    Kneebone, A.
    Martin, K.
    Subramanian, S.
    [J]. GUT, 2015, 64 : A91 - A91
  • [33] Antibodies to anti-TNF therapy—consequences for IBD management
    Welmoed K. van Deen
    Daniel W. Hommes
    [J]. Nature Reviews Gastroenterology & Hepatology, 2013, 10 : 446 - 448
  • [34] Anti-TNF drug and antidrug antibody level monitoring in IBD: a practical guide
    Hendy, Philip
    Hart, Ailsa
    Irving, Peter
    [J]. FRONTLINE GASTROENTEROLOGY, 2016, 7 (02) : 122 - 128
  • [35] Real World Experience in Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Lack of Anti-Drug Antibodies to Vedolizumab and Ustekinumab Compared to Anti-TNF Agents in IBD
    Glassner, Kerri L.
    Oglat, Ayah
    Abraham, Bincy
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S342 - S343
  • [36] IBD Antibodies to anti-TNF therapy-consequences for IBD management
    van Deen, Welmoed K.
    Hommes, Daniel W.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (08) : 446 - 448
  • [37] Letter: predictive factors for treatment discontinuation in IBD-anti-TNF trough levels and anti-drug antibodies
    Demarzo, Maria Giulia
    Bodini, Giorgia
    Giuliana, Elisabetta
    Zentilin, Patrizia
    Giannini, Edoardo G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (04) : 536 - 537
  • [38] Anti-TNF and Anti-Drug Antibodies Levels Predict the Outcomes of Interventions After Loss of Response to Adalimumab and Infliximab
    Yanai, Henit
    Lichtenstein, Lev
    Assa, Amit
    Mazor, Yoav
    Weiss, Batia
    Levine, Arie
    Ron, Yulia
    Kopylov, Uri
    Bujanover, Yoram
    Rosenbach, Yoram
    Ungar, Bella
    Eliakim, Abraham R.
    Chowers, Yehuda
    Shamir, Raanan
    Fraser, Gerald
    Dotan, Iris
    Ben-Horin, Shomron
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S381 - S381
  • [39] REVERSAL OF ANTI-DRUG ANTIBODIES TO ANTI-TNF THERAPY WITH ADDITION OF IMMUNOMODULATORS: A SYSTEMIC REVIEW AND META-ANALYSIS
    Kucharski, Kimberly
    Kashani, Amir
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S655 - S655
  • [40] INCREASED FREQUENCY OF ANTI-DRUG ANTIBODIES IN PATIENTS CARRYING COMPATIBLE IGG1 ALLOTYPES AND TREATED WITH ANTI-TNF ANTIBODIES
    Lopez-Rodriguez, R.
    Martinez, A.
    Plasencia, C.
    Jochems, A.
    Pascual-Salcedo, D.
    Balsa, A.
    Gonzalez, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 59 - 59
12345